Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSL ( (AU:CSL) ) just unveiled an announcement.
CSL Limited has announced the details for its 2025 Annual General Meeting, scheduled to take place on October 28, 2025, at the RACV Club in Melbourne. This meeting is a significant event for shareholders, providing an opportunity to discuss the company’s performance and future strategies, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (AU:CSL) stock is a Buy with a A$232.00 price target. To see the full list of analyst forecasts on CSL stock, see the AU:CSL Stock Forecast page.
More about CSL
CSL Limited is a global biotechnology company based in Melbourne, Australia. It specializes in the development and manufacturing of innovative biotherapies and influenza vaccines, focusing on improving the health and well-being of people worldwide.
Average Trading Volume: 1,066,169
Technical Sentiment Signal: Sell
Current Market Cap: A$99.2B
See more data about CSL stock on TipRanks’ Stock Analysis page.